TRanscriptomic Analysis of Circulating Endothelial Cells During Sepsis - TRACES Study
NCT04841824 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2021-04-12
Summary
Vascular dysfunction is an important mechanism involved in organ failure, in the setting of sepsis condition, with different types of circulating endothelial cells.Transcriptom analysis via RNAseq in different types of circulating endothelial cells, comapring critically ill patients with or without sepsis will allow determining differential gene expression for signal pathways in endothelial alteration and restoration associated with sepsis.
Conditions
- Critical Illness With or Without Sepsis
Interventions
- OTHER
-
Observational study
Observational study. Groups are defined based on baseline patients' characteristics : presence or absence of sepsis.
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-30
- Primary Completion
- 2026-04-30
- Completion
- 2026-08-31
Countries
- France
Study Locations
More Related Trials
-
A Study to Learn About the Occurrence of Disseminated Intravascular Coagulation in People With Sepsis and Further Worsening of Sepsis
NCT06986798 ·Status: COMPLETED ·Phase: NA
-
Effects of Norepinephrine and Volume Expansion in Capillary Refill Time in Septic Shock
NCT04870892 ·Status: UNKNOWN
-
Combined Determination of sTREM-1, PCT and CD64 in Diagnosing Sepsis
NCT02198950 ·Status: COMPLETED
-
Study of the Role of Interferon αon the Endothelial Dysfunction During Septic Shock
NCT04204694 ·Status: UNKNOWN
-
Septic Shock-induced Immunosuppression
NCT04067674 ·Status: RECRUITING
-
Personalized Mean Arterial Pressure Management on Renal Function During Septic Shock
NCT01473498 ·Status: TERMINATED ·Phase: NA
-
Adrenomedullin and Outcome in Severe Sepsis and Septic Shock
NCT02393781 ·Status: COMPLETED
-
Early PREdiction of Severe Sepsis I (ExPRES-Sepsis I) Study
NCT02188992 ·Status: COMPLETED
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Microcirculation Guided Therapy Versus "Standard Treatment" of Severe Sepsis
NCT00484133 ·Status: UNKNOWN ·Phase: PHASE4
-
Optimization of Sepsis Therapy Based on Patient-specific Digital Precision Diagnostics
NCT04571801 ·Status: COMPLETED ·Phase: NA
-
The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells
NCT05570643 ·Status: COMPLETED ·Phase: NA
-
TRIAGE: TRIage of Sepsis At emerGency dEpartment
NCT02739152 ·Status: COMPLETED
-
Treatment of Severe Infections With Mesenchymal Stem Cells
NCT02883803 ·Status: UNKNOWN ·Phase: NA
-
Regulation of Endocrine, Metabolic, Immune and Bioenergetic Responses in Sepsis
NCT00187824 ·Status: UNKNOWN
-
Characterization of Hemostatic Disordres in Septic Shock: Searching for Biological Markers
NCT02692053 ·Status: UNKNOWN ·Phase: NA
-
Haemofiltration Study : IVOIRE (hIgh VOlume in Intensive Care)
NCT00241228 ·Status: COMPLETED ·Phase: NA
-
Early Vasopressors in Sepsis
NCT05179499 ·Status: RECRUITING ·Phase: PHASE3
-
Biomarkers for the Early Identification of Sepsis in the Emergency Department
NCT02707718 ·Status: COMPLETED
-
Therapeutic Plasmaexchange in Early Septic Shock
NCT04231994 ·Status: COMPLETED ·Phase: PHASE2
-
Microcirculatory Alterations in Critical Disease: New Ultrasound Technology
NCT03311568 ·Status: TERMINATED ·Phase: NA
-
REmote Ischemic COnditioning in Septic Shock
NCT03201575 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Immunosuppression in Septic Shock: Biomarkers and Pharmacological Restoration (IMMUNOSEPSIS)
NCT02803346 ·Status: UNKNOWN
-
Effects of Fluid Therapy on Peripheral TIssse Perfusion During Sepsis/Septic Shock
NCT05094856 ·Status: COMPLETED
-
Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis
NCT00406198 ·Status: COMPLETED ·Phase: PHASE4